Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P63763

Entry ID Method Resolution Chain Position Source
AF-P63763-F1 Predicted AlphaFoldDB

No variants for P63763

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for P63763

No associated diseases with P63763

9 regional properties for P63763

Type Name Position InterPro Accession
domain Elongation factor EFG, domain V-like 620 - 709 IPR000640
domain Translational (tr)-type GTP-binding domain 8 - 290 IPR000795
domain Translation elongation factor EFTu-like, domain 2 331 - 398 IPR004161
domain Small GTP-binding protein domain 10 - 186 IPR005225
domain Translation elongation factor EFG/EF2, domain IV 486 - 618 IPR005517
domain Elongation factor G, domain III 412 - 487 IPR009022
conserved_site Tr-type G domain, conserved site 51 - 66 IPR031157
domain EFG, domain V 623 - 702 IPR035649
domain Elongation Factor G, domain II 411 - 484 IPR041095

Functions

Description
EC Number 2.4.1.129 Hexosyltransferases
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
  • Localizes to the division septum
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

1 GO annotations of molecular function

Name Definition
peptidoglycan glycosyltransferase activity Catalysis of the reaction: [GlcNAc-(1,4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)](n)-diphosphoundecaprenol + GlcNAc-(1,4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol = [GlcNAc-(1,4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)](n+1)-diphosphoundecaprenol + undecaprenyl diphosphate.

5 GO annotations of biological process

Name Definition
cell cycle The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.
cell division The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells.
cell wall organization A process that results in the assembly, arrangement of constituent parts, or disassembly of the cell wall, the rigid or semi-rigid envelope lying outside the cell membrane of plant, fungal and most prokaryotic cells, maintaining their shape and protecting them from osmotic lysis.
peptidoglycan biosynthetic process The chemical reactions and pathways resulting in the formation of peptidoglycans, any of a class of glycoconjugates found in bacterial cell walls.
regulation of cell shape Any process that modulates the surface configuration of a cell.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MLTRLLRRGT SDTDGSQTRG AEPVEGQRTG PEEASNPGSA RPRTRFGAWL GRPMTSFHLI
70 80 90 100 110 120
IAVAALLTTL GLIMVLSASA VRSYDDDGSA WVIFGKQVLW TLVGLIGGYV CLRMSVRFMR
130 140 150 160 170 180
RIAFSGFAIT IVMLVLVLVP GIGKEANGSR GWFVVAGFSM QPSELAKMAF AIWGAHLLAA
190 200 210 220 230 240
RRMERASLRE MLIPLVPAAV VALALIVAQP DLGQTVSMGI ILLGLLWYAG LPLRVFLSSL
250 260 270 280 290 300
AAVVVSAAIL AVSAGYRSDR VRSWLNPEND PQDSGYQARQ AKFALAQGGI FGDGLGQGVA
310 320 330 340 350 360
KWNYLPNAHN DFIFAIIGEE LGLVGALGLL GLFGLFAYTG MRIASRSADP FLRLLTATTT
370 380 390 400 410 420
LWVLGQAFIN IGYVIGLLPV TGLQLPLISA GGTSTAATLS LIGIIANAAR HEPEAVAALR
430 440 450 460 470 480
AGRDDKVNRL LRLPLPEPYL PPRLEAFRDR KRANPQPAQT QPARKTPRTA PGQPARQMGL
490 500 510 520
PPRPGSPRTA DPPVRRSVHH GAGQRYAGQR RTRRVRALEG QRYG